bioMerieux (OTCMKTS:BMXMF – Get Free Report) crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $126.48 and traded as low as $125.2550. bioMerieux shares last traded at $125.2550, with a volume of 9 shares changing hands.
bioMerieux Price Performance
The company has a current ratio of 2.27, a quick ratio of 1.30 and a debt-to-equity ratio of 0.08. The business’s 50-day moving average is $126.48 and its 200-day moving average is $135.64.
bioMerieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Read More
- Five stocks we like better than bioMerieux
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Dave & Buster’s Reversal Is in PLAY After Double-Bottom Breakout
- What is a Death Cross in Stocks?
- 3 Finance Stocks to Buy on Rising 10-Year Treasury Rates
- The 3 Best Retail Stocks to Shop for in August
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
Receive News & Ratings for bioMerieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMerieux and related companies with MarketBeat.com's FREE daily email newsletter.
